Gary Palmer
Corporate Officer/Principal at The State Bar of California
Profile
Gary Palmer is a professional with a doctorate from Stanford University, a graduate degree from the University of California, Los Angeles, an undergraduate degree from Yale University, a graduate degree from Concord University, and a Master's in Business Administration from the University of California.
He is currently a member of The State Bar of California.
Previously, he held positions at Amgen, Inc. as an Associate Medical Director, Kosan Biosciences, Inc. as an Executive Director, Salmedix, Inc. as a Senior Director, the University of California, Davis as a Director-Medical Breast Services, and Genomic Health, Inc. as a Vice President-Medical Affairs.
He was also the President-GPS Operations at NantHealth, Inc. and the Chief Medical Officer & Head-Development at On-Q-ity, Inc. He served as the Senior VP-Medical Affairs & Commercial Development at Foundation Medicine, Inc. from 2011 to 2015.
Gary Palmer active positions
| Companies | Position | Start |
|---|---|---|
The State Bar of California
 The State Bar of California Miscellaneous Commercial ServicesCommercial Services The State Bar of California operates as an official attorney licensing agency. The non-profit company is based in San Francisco, CA. Elizabeth Rindskopf Parker has been the CEO of the company since 2015. | Corporate Officer/Principal | - |
Former positions of Gary Palmer
| Companies | Position | End |
|---|---|---|
| NANTHEALTH, INC. | Chief Tech/Sci/R&D Officer | 29/02/2016 |
| FOUNDATION MEDICINE INC | Chief Tech/Sci/R&D Officer | 31/10/2015 |
On-Q-ity, Inc.
 On-Q-ity, Inc. Medical/Nursing ServicesHealth Services On-Q-ity is an innovative diagnostic company that is focused on providing physicians with the tools they need to make the best decision when treating individual cancer patients. Its circulating tumor cell technology will enable better decision-making across multiple cancers: improving the quality of life for patients and ultimately increasing survival. On-Q-ity's products and services are based on its unique and proprietary circulating tumor cell (CTC) technology which enables them to capture, count and characterize CTCs from a sample of patient blood. Through proprietary circulating tumor cell (CTC) and biomarker technology, they are creating products designed to non-invasively monitor and optimize cancer care throughout the disease cycle. They invite companies with complementary technologies, innovative biomarkers, and special expertise in its field to explore partnering relationships. | Chief Tech/Sci/R&D Officer | 31/12/2010 |
| AMGEN INC. | Director/Board Member | 31/12/2002 |
| University of California, Davis | Corporate Officer/Principal | - |
Training of Gary Palmer
| Concord University | Graduate Degree |
| Yale University | Undergraduate Degree |
| Stanford University | Doctorate Degree |
| University of California | Masters Business Admin |
| University of California, Los Angeles | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| NANTHEALTH, INC. | Technology Services |
| Private companies | 6 |
|---|---|
Foundation Medicine, Inc.
 Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Foundation Medicine, Inc. is a molecular information company, which engages in the provision of information on clinical treatment decisions for patients with cancer. The company was founded on January 10, 2010 and is headquartered in Cambridge, MA. | Health Services |
On-Q-ity, Inc.
On-Q-ity, Inc. Medical/Nursing ServicesHealth Services On-Q-ity is an innovative diagnostic company that is focused on providing physicians with the tools they need to make the best decision when treating individual cancer patients. Its circulating tumor cell technology will enable better decision-making across multiple cancers: improving the quality of life for patients and ultimately increasing survival. On-Q-ity's products and services are based on its unique and proprietary circulating tumor cell (CTC) technology which enables them to capture, count and characterize CTCs from a sample of patient blood. Through proprietary circulating tumor cell (CTC) and biomarker technology, they are creating products designed to non-invasively monitor and optimize cancer care throughout the disease cycle. They invite companies with complementary technologies, innovative biomarkers, and special expertise in its field to explore partnering relationships. | Health Services |
Genomic Health, Inc.
 Genomic Health, Inc. Medical SpecialtiesHealth Technology Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. The firm uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. The company was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott, and Steven Shak in August 2000 and is headquartered in Redwood City, CA. | Health Technology |
Kosan Biosciences, Inc.
 Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Health Technology |
Salmedix, Inc.
 Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | Health Technology |
The State Bar of California
The State Bar of California Miscellaneous Commercial ServicesCommercial Services The State Bar of California operates as an official attorney licensing agency. The non-profit company is based in San Francisco, CA. Elizabeth Rindskopf Parker has been the CEO of the company since 2015. | Commercial Services |
- Stock Market
- Insiders
- Gary Palmer
